Natera at NSGC 2024

Join us at the NSGC Annual Conference

September 17-21, 2024

New Orleans | Ernest N. Morial Convention Center

Booth #210

Learning Theater

Paving the way for a new approach for Rh negative pregnancies: Clinical validation of a SNP-based NIPT for fetal RhD

Dates: Wednesday, September 18th | Thursday, September 19th, 2024

Time: 1:00 - 1:30 PM CDT

Room: Convention Center, Exhibit Hall Learning Theater

Speaker: Katherine Krepkovich, MS, CGC, Natera

Katie Krepkovich, Medical Science Liaison at Natera, will present new data from the largest clinical validation study for fetal RhD to date in the US, with 650+ Rh negative pregnant people and confirmation by serology on all newborns. The presentation will discuss how fetal RhD NIPT adds to current management of pregnant people who are Rh negative, helping to inform the use of RhD immune globulin for antenatal prophylaxis.

Cancer Special Interest Group (SIG) Happy Hour

Driving Hereditary Cancer Testing & Precision Patient Management in Oncology

Date: Thursday, September 19th, 2024

Time: 4:30 - 5:30 PM CDT

Room: Convention Center, Room 288-290

Join Natera for a taste of NOLA & a preview of Natera’s new hereditary cancer program offerings.

Enjoy happy hour specialty hors d'oeuvres and cocktails showcasing the vibrance of The Big Easy. Explore customizable gene and panel options and patient access support with the Natera Empower™ Hereditary Cancer Test. Learn about the new Hereditary Cancer Alert Program (HCAP) utilizing the Signatera™ Residual Disease Test (MRD), which increased at-risk patients receiving hereditary cancer testing by 200% in a pilot study.